[ Download Slide ]

Summary statistics on reported ESRD therapy in the United States, 2005

A- Incident counts: include all known ESRD patients, regardless of any incomplete data on patient characteristics and of U.S. residency status.
B- Includes only residents of the 50 states and Washington D.C. Rates are adjusted for age, race, and/or gender using the estimated July 1, 2004 U.S. resident population as the standard population. All rates are per million population. Rates by age are adjusted for race and gender. Rates by gender are adjusted for race and age. Rates by race are adjusted for age and gender. Rates by disease group and total adjusted rates are adjusted for age, gender, and race. Adjusted rates do not include patients with other or unknown race.
C- Patients are classified as receiving dialysis or having a functioning transplant. Those whose treatment modality on December 31 is unknown are assumed to be receiving dialysis. Includes all Medicare and non-Medicare ESRD patients, and patients in the U.S. Territories and foreign countries.
D- Deaths are not counted for patients whose age is unknown.
E- Age is computed at the start of therapy for incidence, on December 31 for point prevalence, at the time of transplant for transplants, and on the date of death for death.
F- Includes patients whose modality is unknown.
G- Unadjusted total rates include all ESRD patients in the 50 states and Washington D.C.
H- Total transplants as known to the USRDS; 54 transplants with unknown donor type excluded from counts.
I- Adjustments using the CMS inflation adjustment for the medical component, and the Bureau of Labor Statistics inflationary adjustment.
* Values for cells with ten or fewer patients are suppressed. “.” Zero patients in this cell.